Teresa Mannarino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Teresa Mannarino has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Cuocolo
Department of Advanced Biomedical Sciences, University of Naples “Federico II”, Naples, Italy
6 shared publications - Emilia Zampella
Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy
6 shared publications Roberta Assante
Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy
5 shared publications- Wanda Acampa
Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy (W.A.).
5 shared publications - Carmela Nappi
Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
4 shared publications - Mario Petretta
Department of Advanced Biomedical Sciences, University of Naples Federico II
4 shared publications
Latest Publications
- Open Access
- 20 November 2025
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 58, 102564
Improved risk stratification with noninvasive measures of myocardial flow reserve by low-dose dynamic imaging by cadmium-zinc-telluride–single photon emission computerized tomography in patients with suspected or known coronary artery disease
- 20 November 2025
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 58, 102564
Open AccessImproved risk stratification with noninvasive measures of myocardial flow reserve by low-dose dynamic imaging by cadmium-zinc-telluride–single photon emission computerized tomography in patients with suspected or known coronary artery disease
- Open Access
- 11 September 2025
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 18 (1) , 1-11
Multimodality Imaging in the Contemporary Work-Up of Cardiac Sarcoidosis
Purpose of Review: This review critically evaluates the most recent literature on the role of various imaging modalities, including echocardiography, computed tomography (CT), cardiac magnetic resonance imaging (CMR), single-photon emission tomography (SPECT) and fluorodeoxyglucose positron emission tomography (FDG-PET) in cardiac sarcoidosis (CS) detection and management. The review also discusses emerging advancements, such as artificial intelligence (AI) integration and hybrid imaging techniques. Recent Findings: CS is a challenging disease to diagnose due to its heterogeneous presentation and often subtle cardiac involvement. Multimodality imaging plays a crucial role in the contemporary work-up of CS, allowing for more accurate diagnosis, risk stratification, and treatment monitoring. Summary: Current imaging techniques, including echocardiography, CMR, SPECT, FDG-PET and hybrid modalities such as PET/CT and PET/MR offer complementary information on myocardial inflammation, fibrosis, and functional impairment, thereby enhancing diagnostic confidence and guiding management decisions. Additionally, emerging applications of artificial intelligence and machine learning are showing promise in automating image interpretation, improving diagnostic precision, and supporting personalized risk stratification. The integration of advanced imaging with AI-driven tools represents a future direction for optimizing clinical outcomes in patients with cardiac sarcoidosis.
- 11 September 2025
- Published by Springer Nature in Current Cardiovascular Imaging Reports
- Vol. 18 (1) , 1-11
Open AccessMultimodality Imaging in the Contemporary Work-Up of Cardiac Sarcoidosis
Purpose of Review: This review critically evaluates the most recent literature on the role of various imaging modalities, including echocardiography, computed tomography (CT), cardiac magnetic resonance imaging (CMR), single-photon emission tomography (SPECT) and fluorodeoxyglucose positron emission tomography (FDG-PET) in cardiac sarcoidosis (CS) detection and management. The review also discusses emerging advancements, such as artificial intelligence (AI) integration and hybrid imaging techniques. Recent Findings: CS is a challenging disease to diagnose due to its heterogeneous presentation and often subtle cardiac involvement. Multimodality imaging plays a crucial role in the contemporary work-up of CS, allowing for more accurate diagnosis, risk stratification, and treatment monitoring. Summary: Current imaging techniques, including echocardiography, CMR, SPECT, FDG-PET and hybrid modalities such as PET/CT and PET/MR offer complementary information on myocardial inflammation, fibrosis, and functional impairment, thereby enhancing diagnostic confidence and guiding management decisions. Additionally, emerging applications of artificial intelligence and machine learning are showing promise in automating image interpretation, improving diagnostic precision, and supporting personalized risk stratification. The integration of advanced imaging with AI-driven tools represents a future direction for optimizing clinical outcomes in patients with cardiac sarcoidosis.
- Open Access
- 27 August 2025
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 23 (1) , 1-5
Multimodal imaging in young male with bicuspid aortic valve, right-sided aorto-atrial fistula and single coronary artery
A 35-year-old male, without significant cardiovascular history, presented with recurrent palpitations. Initial echocardiographic evaluation demonstrated eccentric left ventricular hypertrophy, mild systolic dysfunction, suspicion of a ventricular septal defect, bicuspid aortic valve, and right ventricular dilation. Transesophageal echocardiography revealed an aneurysmal dilation of the right coronary sinus with an aorto-atrial/ventricular fistula, further confirmed by contrast-enhanced computed tomography angiography. Coronary angiography identified a single anomalous coronary artery with left dominance and absence of the right coronary artery. Surgical repair successfully closed the fistula, with mild post-operative aortic regurgitation. Follow-up at one year indicated normalization of cardiac dimensions and function, with stable moderate aortic valve regurgitation. Genetic sequencing found no identifiable mutations. Regular monitoring was recommended due to the potential risk of complications related to the bicuspid aortic valve and coronary anomaly.
- 27 August 2025
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 23 (1) , 1-5
Open AccessMultimodal imaging in young male with bicuspid aortic valve, right-sided aorto-atrial fistula and single coronary artery
A 35-year-old male, without significant cardiovascular history, presented with recurrent palpitations. Initial echocardiographic evaluation demonstrated eccentric left ventricular hypertrophy, mild systolic dysfunction, suspicion of a ventricular septal defect, bicuspid aortic valve, and right ventricular dilation. Transesophageal echocardiography revealed an aneurysmal dilation of the right coronary sinus with an aorto-atrial/ventricular fistula, further confirmed by contrast-enhanced computed tomography angiography. Coronary angiography identified a single anomalous coronary artery with left dominance and absence of the right coronary artery. Surgical repair successfully closed the fistula, with mild post-operative aortic regurgitation. Follow-up at one year indicated normalization of cardiac dimensions and function, with stable moderate aortic valve regurgitation. Genetic sequencing found no identifiable mutations. Regular monitoring was recommended due to the potential risk of complications related to the bicuspid aortic valve and coronary anomaly.
- Open Access
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 17 (11) , e016815
Prognostic Value of Coronary Flow Capacity by 82 Rb PET in Patients With Suspected Coronary Artery Disease and Normal Myocardial Perfusion at Semiquantitative Imaging Analysis
BACKGROUND: Coronary flow capacity (CFC) is a measure that integrates hyperemic myocardial blood flow and myocardial flow reserve to quantify the pathophysiological impact of coronary artery disease on vasodilator capacity. We assessed the prognostic value of CFC derived from 82 Rb positron emission tomography/computed tomography in patients with suspected coronary artery disease and normal myocardial perfusion imaging. METHODS: We studied 1967 patients with suspected coronary artery disease and normal myocardial perfusion at the semiquantitative analysis of stress/rest cardiac 82 Rb positron emission tomography/computed tomography imaging. Coronary artery calcium scores were calculated and categorized into 3 groups: 0, 0.1 to 99.9, and ≥100. Patients were classified as having myocardial steal, severely reduced CFC, moderately reduced CFC, mildly reduced CFC, minimally reduced CFC, or normal flow using previously defined thresholds. The outcome end points were myocardial infarction and cardiac death, whichever occurred first. RESULTS: During a mean time of 41±27 months, 49 events occurred (2.5% cumulative event rate, with an annualized event rate of 0.5% person-years). At multivariable Cox analysis, coronary artery calcium score categories and impaired CFC resulted as independent predictors of events (both P P <0.05). Kaplan-Meier analysis showed that patients with impaired CFC were at the highest risk of events. CONCLUSIONS: In patients with suspected coronary artery disease and normal myocardial perfusion, impaired CFC is associated with a higher risk of cardiac events. Evaluating CFC can help identify patients’ candidates for additional therapies to prevent future events.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 17 (11) , e016815
Open AccessPrognostic Value of Coronary Flow Capacity by 82 Rb PET in Patients With Suspected Coronary Artery Disease and Normal Myocardial Perfusion at Semiquantitative Imaging Analysis
BACKGROUND: Coronary flow capacity (CFC) is a measure that integrates hyperemic myocardial blood flow and myocardial flow reserve to quantify the pathophysiological impact of coronary artery disease on vasodilator capacity. We assessed the prognostic value of CFC derived from 82 Rb positron emission tomography/computed tomography in patients with suspected coronary artery disease and normal myocardial perfusion imaging. METHODS: We studied 1967 patients with suspected coronary artery disease and normal myocardial perfusion at the semiquantitative analysis of stress/rest cardiac 82 Rb positron emission tomography/computed tomography imaging. Coronary artery calcium scores were calculated and categorized into 3 groups: 0, 0.1 to 99.9, and ≥100. Patients were classified as having myocardial steal, severely reduced CFC, moderately reduced CFC, mildly reduced CFC, minimally reduced CFC, or normal flow using previously defined thresholds. The outcome end points were myocardial infarction and cardiac death, whichever occurred first. RESULTS: During a mean time of 41±27 months, 49 events occurred (2.5% cumulative event rate, with an annualized event rate of 0.5% person-years). At multivariable Cox analysis, coronary artery calcium score categories and impaired CFC resulted as independent predictors of events (both P P <0.05). Kaplan-Meier analysis showed that patients with impaired CFC were at the highest risk of events. CONCLUSIONS: In patients with suspected coronary artery disease and normal myocardial perfusion, impaired CFC is associated with a higher risk of cardiac events. Evaluating CFC can help identify patients’ candidates for additional therapies to prevent future events.
- Open Access
- 13 September 2023
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (9) , 395
Age-Specific Cardiovascular Risk Factors for Major Adverse Cardiac Events in Patients Undergoing Myocardial Perfusion Imaging
Background: The prevalence of traditional cardiovascular risk factors shows different age-specific patterns. It is not known whether the prognostic impact of risk factors is similarly age-specific. We evaluated the profiles of cardiovascular risk factors and their prognostic impact on coronary artery disease (CAD) in relation to age. Methods: We included 3667 patients with suspected or known CAD undergoing stress myocardial perfusion imaging (MPI). We evaluated the risk for major adverse cardiac events (MACE) within three years from the index MPI in patients belonging to three groups according to age tertile distribution: 68 years. Gender, body mass index, diabetes, hypertension, dyslipidemia, family history of CAD, smoking, angina, dyspnea, previous CAD, and MPI outcome were assessed as risk factors by a multivariable Cox’s regression. Results: The three-year risk of MACE increased progressively with age and was 9%, 13%, and 18% for each group, respectively (p < 0.0001). Dyspnea and abnormal MPI outcome were significant risk factors for all age groups. Diabetes and smoking were significant from the age of 59 onwards, while hypertension resulted significant for patients older than 68 years. Conclusions: The number of risk factors was significantly associated with the occurrence of MACE increase with age. It is noteworthy that a personal history of CAD was not useful for risk stratification, while MPI results were.
- 13 September 2023
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (9) , 395
Open AccessAge-Specific Cardiovascular Risk Factors for Major Adverse Cardiac Events in Patients Undergoing Myocardial Perfusion Imaging
Background: The prevalence of traditional cardiovascular risk factors shows different age-specific patterns. It is not known whether the prognostic impact of risk factors is similarly age-specific. We evaluated the profiles of cardiovascular risk factors and their prognostic impact on coronary artery disease (CAD) in relation to age. Methods: We included 3667 patients with suspected or known CAD undergoing stress myocardial perfusion imaging (MPI). We evaluated the risk for major adverse cardiac events (MACE) within three years from the index MPI in patients belonging to three groups according to age tertile distribution: 68 years. Gender, body mass index, diabetes, hypertension, dyslipidemia, family history of CAD, smoking, angina, dyspnea, previous CAD, and MPI outcome were assessed as risk factors by a multivariable Cox’s regression. Results: The three-year risk of MACE increased progressively with age and was 9%, 13%, and 18% for each group, respectively (p < 0.0001). Dyspnea and abnormal MPI outcome were significant risk factors for all age groups. Diabetes and smoking were significant from the age of 59 onwards, while hypertension resulted significant for patients older than 68 years. Conclusions: The number of risk factors was significantly associated with the occurrence of MACE increase with age. It is noteworthy that a personal history of CAD was not useful for risk stratification, while MPI results were.
- 3 August 2023
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 50 (13) , 1-3
Exploring coronary microvascular function by quantitative CZT-SPECT: a small step or giant leap for INOCA patients?
- 3 August 2023
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 50 (13) , 1-3
Exploring coronary microvascular function by quantitative CZT-SPECT: a small step or giant leap for INOCA patients?
- 14 February 2023
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 104 (7-8) , 323-329
Myocardial blood flow evaluation with dynamic cadmium-zinc-telluride single-photon emission computed tomography: Bright and dark sides
- 14 February 2023
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 104 (7-8) , 323-329
Myocardial blood flow evaluation with dynamic cadmium-zinc-telluride single-photon emission computed tomography: Bright and dark sides
- Open Access
- 11 August 2020
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 48 (2) , 421-427
Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease
Purpose We assessed the effects of the COVID-19 pandemic on myocardial perfusion imaging (MPI) for ischemic heart disease during the lockdown imposed by the Italian Government. Methods We retrospectively reviewed the number and the findings of stress single-photon emission computed tomography (SPECT)-MPI performed between February and May 2020 during the COVID-19 pandemic at the University of Napoli Federico II. The number and the findings of stress SPECT-MPI studies acquired in the corresponding months of the years 2017, 2018, and 2019 were also evaluated for direct comparison. Results The number of stress SPECT-MPI studies performed during the COVID-19 pandemic (n = 123) was significantly lower (P < 0.0001) compared with the mean yearly number of procedures performed in the corresponding months of the years 2017, 2018, and 2019 (n = 413). Yet, the percentage of abnormal stress SPECT-MPI studies was similar (P = 0.65) during the pandemic (36%) compared with the mean percentage value of the corresponding period of the years 2017, 2018, and 2019 (34%). Conclusion The number of stress SPECT-MPI studies was significantly reduced during the COVID-19 pandemic compared with the corresponding months of the previous 3 years. The lack of difference in the prevalence of abnormal SPECT-MPI studies between the two study periods strongly suggests that many patients with potentially abnormal imaging test have been missed during the pandemic.
- 11 August 2020
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 48 (2) , 421-427
Open AccessEffects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease
Purpose We assessed the effects of the COVID-19 pandemic on myocardial perfusion imaging (MPI) for ischemic heart disease during the lockdown imposed by the Italian Government. Methods We retrospectively reviewed the number and the findings of stress single-photon emission computed tomography (SPECT)-MPI performed between February and May 2020 during the COVID-19 pandemic at the University of Napoli Federico II. The number and the findings of stress SPECT-MPI studies acquired in the corresponding months of the years 2017, 2018, and 2019 were also evaluated for direct comparison. Results The number of stress SPECT-MPI studies performed during the COVID-19 pandemic (n = 123) was significantly lower (P < 0.0001) compared with the mean yearly number of procedures performed in the corresponding months of the years 2017, 2018, and 2019 (n = 413). Yet, the percentage of abnormal stress SPECT-MPI studies was similar (P = 0.65) during the pandemic (36%) compared with the mean percentage value of the corresponding period of the years 2017, 2018, and 2019 (34%). Conclusion The number of stress SPECT-MPI studies was significantly reduced during the COVID-19 pandemic compared with the corresponding months of the previous 3 years. The lack of difference in the prevalence of abnormal SPECT-MPI studies between the two study periods strongly suggests that many patients with potentially abnormal imaging test have been missed during the pandemic.
- 20 April 2018
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 27 (2) , 534-541
Warranty period of normal stress myocardial perfusion imaging in hypertensive patients: A parametric survival analysis
- 20 April 2018
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 27 (2) , 534-541
Warranty period of normal stress myocardial perfusion imaging in hypertensive patients: A parametric survival analysis